dailymed zepbound tirzepatide label FDA approves weight-loss drug to treat sleep apnea Tirzepatide vs. Semaglutide for Weight

With its dual action on appetite regulation and blood sugar control, tirzepatide stands out from other weight loss medications

After 24 weeks of treatment with either placebo, Pegozafermin 15 mg weekly, Pegozafermin 30 mg weekly, or Pegozafermin 44 mg every two weeks, the proportions of patients achieving fibrosis improvement were 7%, 22%, 26%, and 27%, respectively

Atypical (second-generation) antipsychotics Drug Safety Update

PlexusDx Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan)a flat rate that never increases with doseand the Precision Peptide Genetic Test is available as $298, helping patients make informed, genetically-informed choices about their therapy

Early data suggests both medications primarily reduce fat mass, with proportionally smaller losses of lean tissue